Patents by Inventor Xilin SUN

Xilin SUN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12217069
    Abstract: An operation sequence adding method, an electronic device, and a system are provided. The method includes: detecting a first operation performed by a user on a first control; obtaining an event type of the first operation and name information of a first application in response to the first operation; displaying a second interface of the first application in response to the first operation, and detecting a second operation performed by the user on a second control; obtaining a second control identifier and an event type of the second operation in response to the second operation; saving the name information of the first application, the second control identifier, and the event type of the second operation; displaying a third interface of a second application, where the third interface of the second application includes a third control; detecting a third operation performed by the user on the third control; and displaying the second interface of the first application in response to the third operation.
    Type: Grant
    Filed: June 16, 2023
    Date of Patent: February 4, 2025
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Xilin Sun, Jie Li, Yinzhu Cheng, Min Liu, Cheng Liu
  • Patent number: 12146932
    Abstract: A magnetic resonance imaging (MRI) system and method integrating multi-nuclide synchronous imaging and spectral imaging is provided. The MRI system includes a spectral imaging module, a multi-nuclide synchronous imaging module, and a spectral reconstruction and image fusion module, where the spectral imaging module is configured to acquire a spectrum of a nuclide Nuc; the multi-nuclide synchronous imaging module is configured to perform synchronous imaging of nuclides Nuc1 . . . Nucn, where when n=1, Nucl is 1H; and when n>1, Nucn is a non-1H nuclide; and the spectral reconstruction and image fusion module is configured to receive the spectrum of the nuclide Nuc and images of the nuclides Nuc1 . . . Nucn, and acquire spatial distribution information of compounds of the nuclide Nuc and spatial distribution information of the non-1H nuclide through fusion. The system and method can synchronously acquire MR signals of different nuclides, and reconstruct and fuse non-1H nuclide images.
    Type: Grant
    Filed: February 21, 2024
    Date of Patent: November 19, 2024
    Assignee: HARBIN MEDICAL UNIVERSITY
    Inventors: Xilin Sun, Chunsheng Yang, Kai Wang, Yongyi Wu, Lijiao Wang, Lili Yang, Lina Wu
  • Publication number: 20240303024
    Abstract: The method includes: In response to receiving a first indication, a first electronic device displays a first interface and sends first information to a second electronic device, where the first information includes one or more interface elements on the first interface and label information of the one or more interface elements. The second electronic device displays a second interface based on the label information of the one or more interface elements in response to receiving the first information, where the second interface displays at least part of the one or more interface elements.
    Type: Application
    Filed: March 29, 2022
    Publication date: September 12, 2024
    Inventors: Jie LI, Min LIU, Xilin SUN, Yinzhu CHENG
  • Publication number: 20240288524
    Abstract: A magnetic resonance imaging (MRI) system and method integrating multi-nuclide synchronous imaging and spectral imaging is provided. The MRI system includes a spectral imaging module, a multi-nuclide synchronous imaging module, and a spectral reconstruction and image fusion module, where the spectral imaging module is configured to acquire a spectrum of a nuclide Nuc; the multi-nuclide synchronous imaging module is configured to perform synchronous imaging of nuclides Nuc1 . . . . Nucn, where when n=1, Nucl is 1H; and when n>1, Nucn is a non-1H nuclide; and the spectral reconstruction and image fusion module is configured to receive the spectrum of the nuclide Nuc and images of the nuclides Nuc1 . . . . Nucn, and acquire spatial distribution information of compounds of the nuclide Nuc and spatial distribution information of the non-1H nuclide through fusion. The system and method can synchronously acquire MR signals of different nuclides, and reconstruct and fuse non-1H nuclide images.
    Type: Application
    Filed: February 21, 2024
    Publication date: August 29, 2024
    Applicant: Harbin Medical University
    Inventors: Xilin SUN, Chunsheng YANG, Kai WANG, Yongyi WU, Lijiao WANG, Lili YANG, Lina WU
  • Publication number: 20240201932
    Abstract: A method includes: a first electronic device displaying a first interface, and sending first information to a second electronic device, where the first information includes one or more interface elements on the first interface and tag information of the interface elements; and the second electronic device displaying a second interface based on the tag information of the one or more interface elements on the first interface, where the second interface includes a first display window and a second display window, at least some interface elements of the one or more interface elements on the first interface are displayed in the first display window, the second display window displays a display interface associated with a first interface element, and the at least some interface elements include the first interface element.
    Type: Application
    Filed: March 29, 2022
    Publication date: June 20, 2024
    Inventors: Xilin Sun, Min Liu, Jie Li, Yinzhu Cheng
  • Publication number: 20230418630
    Abstract: An operation sequence adding method, an electronic device, and a system are provided. The method includes: detecting a first operation performed by a user on a first control; obtaining an event type of the first operation and name information of a first application in response to the first operation; displaying a second interface of the first application in response to the first operation, and detecting a second operation performed by the user on a second control; obtaining a second control identifier and an event type of the second operation in response to the second operation; saving the name information of the first application, the second control identifier, and the event type of the second operation; displaying a third interface of a second application, where the third interface of the second application includes a third control; detecting a third operation performed by the user on the third control; and displaying the second interface of the first application in response to the third operation.
    Type: Application
    Filed: June 16, 2023
    Publication date: December 28, 2023
    Applicant: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Xilin Sun, Jie Li, Yinzhu Cheng, Min Liu, Cheng Liu
  • Patent number: 11389549
    Abstract: The present invention provides a 19F-MR/fluorescence multi-mode molecular imaging and drug loading diagnosis-treatment integrated nanoprobe, and a preparation method and an application. The nano-probe is a nanoparticle formed by coating a mixture of a surfactant containing a molecular targeting treatment drug and a fluorescent dye with a Perfluorocarbon (PFC) carrier; and by uniformly dispersing a mixed solution into water and glycerol, processing ultrasonically, removing a component which is not effectively coated, and purifying, the drug-loading nanoparticle capable of being used for 19 F-MR imaging may be prepared.
    Type: Grant
    Filed: April 23, 2020
    Date of Patent: July 19, 2022
    Assignee: Harbin Medical University
    Inventors: Xilin Sun, Lina Wu, Jie Yang, Kai Wang, Lili Yang, Haoxiang Li, Yingbo Li, Xiaona Li, Shuang Liu
  • Patent number: 11123033
    Abstract: Disclosed is a molecular imaging method for evaluating liver regeneration ability after ALPPS. The method includes steps of: 1) preparing a VX2 rabbit liver cancer model; 2) performing ALPPS for the VX2 rabbit liver cancer model; 3) synthesizing 18F-Fluoromethylcholine (18F-Methylcholine, 18F-FCH); 4) PET/CT imaging and data processing for 18F-FCH. The disclosure is the first to propose the use of 18F-FCH PET/CT to monitor the proliferative capacity of residual liver, and further indirectly reflect the increased ability of cell membrane synthesis on the basis that 18F-FCH has higher choline metabolism in residual liver tissue, so that the liver regeneration ability after ALPPS is evaluated by the molecular imaging method, thereby providing important new ideas for the clinical selection of ALPPS to choose the best time for second-stage surgery.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: September 21, 2021
    Assignee: Harbin Medical University
    Inventors: Xilin Sun, Zhen Quan, Ruifeng Wang, Kai Wang, Lili Yang, Zunyu Xiao, Yang Liu, Zhaoguo Han, Xiang Liu, Mingxing Ke
  • Publication number: 20200261604
    Abstract: The present invention provides a 19F-MR/fluorescence multi-mode molecular imaging and drug loading diagnosis-treatment integrated nanoprobe, and a preparation method and an application. The nano-probe is a nanoparticle formed by coating a mixture of a surfactant containing a molecular targeting treatment drug and a fluorescent dye with a Perfluorocarbon (PFC) carrier; and by uniformly dispersing a mixed solution into water and glycerol, processing ultrasonically, removing a component which is not effectively coated, and purifying, the drug-loading nanoparticle capable of being used for 19 F-MR imaging may be prepared.
    Type: Application
    Filed: April 23, 2020
    Publication date: August 20, 2020
    Inventors: Xilin SUN, Lina WU, Jie YANG, Kai WANG, Lili YANG, Haoxiang LI, Yingbo LI, Xiaona LI, Shuang LIU